Ozurdex
Sponsors
Long Island Vitreoretinal Consultants, McMaster University, Retina Macula Institute, Arman Mashayekhi, The Cleveland Clinic
Conditions
CataractCentral Retinal Vein OcclusionCystoid Macular EdemaDexamethasone Intravitreal ImplantDiabetic Macular EdemaEpiretinal MembraneFibrosis of the RetinaIntraoperative Optical Coherence Tomography
Phase 2
OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab
CompletedNCT01243086
Start: 2011-03-31End: 2015-05-31Updated: 2018-04-06
Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma
TerminatedNCT01471054
Start: 2014-04-30End: 2015-07-31Updated: 2019-09-03
Combination OZURDEX® & EyLea® vs. OZURDEX® Monotherapy in IncompLete-Responders wIth Diabetic Macular Edema
WithdrawnNCT03629210
Start: 2019-09-30End: 2021-05-31Updated: 2019-11-13
Phase 3
Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections.
CompletedNCT01449682
Start: 2011-10-31End: 2013-02-28Updated: 2017-05-31
Multicentre Randomised Clinical Trial Comparing Fixed vs Pro re Nata (PRN) Dosing of 700 μg Dexamethasone
CompletedNCT01892163
Start: 2013-03-31End: 2014-12-31Updated: 2017-02-23
Phase 4
Ozurdex for Diabetic Macular Edema Treated With Pars Plana vitrEctomy and Membrane RemovAl (OPERA Study)
CompletedNCT01613716
Start: 2012-07-31End: 2017-02-28Updated: 2018-05-16
Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion
NCT01827722
Start: 2013-05-31End: 2016-12-31Target: 45Updated: 2015-12-14
Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema
CompletedNCT02036424
Start: 2014-01-31End: 2015-08-31Updated: 2015-12-01
Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema
TerminatedNCT02684084
Start: 2015-11-30End: 2016-12-31Updated: 2018-08-20
Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification
CompletedNCT03832179
Start: 2018-11-15End: 2024-03-30Updated: 2025-09-12
Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China
CompletedNCT03908307
Start: 2019-07-25End: 2021-09-26Updated: 2023-03-31
One Year Trial Evaluating Safety of Ozurdex With Eylea
CompletedNCT03984110
Start: 2019-06-11End: 2022-10-27Updated: 2024-04-10
Compare the Efficacy of VItrectomy Combined With DExamethasone Implant Versus With Aflibercept in DME Patients Diagnosed by Intraoperative OCT (the VIDEO Study): Study Protocol for a Randomized Controlled Trial
NCT05990829
Start: 2023-10-01End: 2025-04-01Target: 64Updated: 2024-03-06
Unknown Phase
Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)
CompletedNCT01231633
Start: 2010-09-30End: 2014-09-30Updated: 2018-04-03
A Pilot Study of the Effectiveness of Intra-operative Ozurdex® in Vitrectomy Surgery for Epiretinal Membranes
NCT01701518
Start: 2012-10-31End: 2016-12-31Target: 15Updated: 2016-01-05
Dexamethasone-Implant for the Treatment of Macula Edema Due to Irvine Gass Syndrome
CompletedNCT01945892
Start: 2011-11-30End: 2013-07-31Updated: 2013-09-19
Retrospective Trial on the Efficacy and Safety of Intravitreal Ozurdex in Patients With Diabetic Macular Edema.
CompletedNCT02121197
Start: 2014-08-31End: 2016-01-31Updated: 2018-05-21
Pro-permeability and Pro-fibrosis Factors in the Aqueous of Patients With Retinal Diseases
TerminatedNCT02688309
Start: 2015-01-13End: 2021-10-28Updated: 2022-07-08